Suppr超能文献

[尘螨所致支气管哮喘的口服免疫疗法疗效]

[Effectiveness of oral immunotherapy in bronchial asthma caused by Dermatophagoides pternyssinus].

作者信息

Pacor M L, Biasi D, Carletto A, Lunardi C

机构信息

Istituto di Clinica Medica, Università, Verona.

出版信息

Recenti Prog Med. 1995 Dec;86(12):489-91.

PMID:8588080
Abstract

We have evaluated the efficacy of oral hyposensitivization in 14 patients suffering from bronchial asthma due to allergy to Dermatophagoides pteronyssinus. The allergen extract was taken in increasing doses and the maximum dose was maintained for the duration of the study (two years). Oral treatment was effective in reducing the number and severity of asthma attacks (p < 0.001) and in improving the respiratory peak flow (p < 0.001). No side effects were observed and all the patients concluded the study. Our results show the efficacy and safety of oral hyposensitization in the treatment of bronchial asthma due to allergy to Dermatophagoides pteronyssinus. Oral therapy avoids the side effects of desensitizing injections which can be serious.

摘要

我们评估了口服减敏疗法对14例因对屋尘螨过敏而患支气管哮喘患者的疗效。变应原提取物剂量递增,最大剂量在研究期间(两年)维持不变。口服治疗在减少哮喘发作次数和严重程度方面有效(p < 0.001),并能改善呼吸峰值流速(p < 0.001)。未观察到副作用,所有患者均完成了研究。我们的结果显示口服减敏疗法治疗因对屋尘螨过敏所致支气管哮喘具有疗效和安全性。口服疗法避免了可能很严重的脱敏注射的副作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验